|
|
Cambridge, Cambridgeshire, CB2 1XJ United Kingdom
phone:(44) (0) 1223 334052
fax:(44) (0) 1223 334052
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
|
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Drug discovery in the areas of pain and obesity. |
|
| Management |
| Robert Brooksbank, M.A. Ph.D., Head of Informatics; Keith Churchman, B.A., Chief Financial Officer; Sandee Collins, B.A., Business Administrator |
| |
|
|
| |
|
| Keywords |
| biotechnology, drug, discovery, pain, obesity, electrophysiological, rna |
|
|
|
| Description |
|
Cambridge Biotechnology (CBT) is involved in drug discovery in the areas of pain and obesity. The company's functional genomics team has developed a proprietary platform for generating gene expression profiles from small numbers of cells. This technology is being applied to identify candidate drug targets based on differences in gene expression between normal and pathological tissue. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members